2023 - Research.com Medicine in Brazil Leader Award
2023 - Research.com Genetics in Brazil Leader Award
2022 - Research.com Genetics and Molecular Biology in Brazil Leader Award
Jeremy A. Squire mainly investigates Genetics, Cancer research, Cancer, Molecular biology and Gene. The Cancer research study combines topics in areas such as Prostate cancer, Stem cell, Tumor suppressor gene, Survival analysis and PTEN. Lung cancer, Adenocarcinoma, Oncology and Internal medicine is closely connected to EGFR Gene Amplification in his research, which is encompassed under the umbrella topic of Survival analysis.
He interconnects Fluorescence in situ hybridization, Haploinsufficiency and Pathology in the investigation of issues within PTEN. His study on Cancer also encompasses disciplines like
His primary areas of investigation include Genetics, Cancer research, Molecular biology, Pathology and Fluorescence in situ hybridization. His study in Genetics concentrates on Gene, Comparative genomic hybridization, Chromosome, Gene duplication and Chromosomal translocation. Jeremy A. Squire combines subjects such as Carcinogenesis, Cancer, Tumor suppressor gene, Prostate cancer and PTEN with his study of Cancer research.
His research in Prostate cancer intersects with topics in Erg, Prostate and Oncology. His research in Molecular biology tackles topics such as Chromosome instability which are related to areas like Genome instability. While the research belongs to areas of Fluorescence in situ hybridization, Jeremy A. Squire spends his time largely on the problem of Karyotype, intersecting his research to questions surrounding Cytogenetics, Aneuploidy, Breakpoint and Ploidy.
His primary scientific interests are in PTEN, Cancer research, Prostate cancer, Internal medicine and Oncology. Jeremy A. Squire has included themes like Immunohistochemistry, Cancer, Prostate, Tumor suppressor gene and Fluorescence in situ hybridization in his PTEN study. His Fluorescence in situ hybridization research is multidisciplinary, incorporating elements of Molecular biology, In situ hybridization and Tissue sections.
His Cancer research study combines topics from a wide range of disciplines, such as Immune checkpoint, Gene expression, DNA damage, Tumor microenvironment and Cancer cell. His work deals with themes such as In silico, Tensin, Genome instability and Pathology, which intersect with Prostate cancer. The various areas that Jeremy A. Squire examines in his Oncology study include Molecular pathology, Guideline, Biomarker, Tissue microarray and Cohort.
His primary areas of study are Prostate cancer, Cancer research, PTEN, Internal medicine and Oncology. The Prostate cancer study combines topics in areas such as Chromosome instability, Breast cancer, Prostate and Pathology. His studies link Fluorescence in situ hybridization with Pathology.
Jeremy A. Squire has researched Cancer research in several fields, including Gene expression profiling, Mdm2, Cell cycle, Regulation of gene expression and Drug resistance. His PTEN study integrates concerns from other disciplines, such as Fusion gene, Genome, Genome instability, In silico and Candidate gene. His Oncology study incorporates themes from Prostate-specific antigen, Guideline, Molecular pathology and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of human brain tumour initiating cells
Sheila K. Singh;Cynthia Hawkins;Ian D. Clarke;Jeremy A. Squire.
Identification of a Cancer Stem Cell in Human Brain Tumors
Sheila K. Singh;Ian D. Clarke;Mizuhiko Terasaki;Victoria E. Bonn.
Cancer Research (2003)
Erlotinib in lung cancer - molecular and clinical predictors of outcome.
Ming Sound Tsao;Akira Sakurada;Jean Claude Cutz;Jean Claude Cutz;Chang Qi Zhu;Chang Qi Zhu.
The New England Journal of Medicine (2005)
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman;Philip T. Cagle;Mary Beth Beasley;Dhananjay Arun Chitale.
Journal of Thoracic Oncology (2013)
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.
Steven M. Pollard;Koichi Yoshikawa;Ian D. Clarke;Davide Danovi.
Cell Stem Cell (2009)
Mutations in SUFU predispose to medulloblastoma
Michael D. Taylor;Ling Liu;Corey Raffel;Chi-chung Hui.
Nature Genetics (2002)
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
Chang Qi Zhu;Gilda Da Cunha Santos;Keyue Ding;Akira Sakurada.
Journal of Clinical Oncology (2008)
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer.
Delphine Lechardeur;K. J. Sohn;M. Haardt;P. B. Joshi.
Gene Therapy (1999)
High-resolution mapping of mammalian genes by in situ hybridization to free chromatin.
H. H. Q. Heng;J. Squire;Lap-Chee Tsui.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
Rosanna Weksberg;Ding Ren Shen;Yan Ling Fei;Qian Li Song.
Nature Genetics (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: